Moolec Science (MLECW) Intangibles (2022 - 2026)
Moolec Science (MLECW) posted Intangibles of $71.6 million for Q1 2026, little changed sequentially from $71.6 million in Q4 2025.
Moolec Science (MLECW) Intangibles (2022 - 2026) Analysis & Trends
Moolec Science has reported Intangibles for 5 years, with the latest figure at $71.6 million in Q1 2026.
- Quarterly Intangibles changed N/A year-over-year to $71.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71.6 million (changed N/A YoY) and the FY2025 annual result came in at $75.3 million, down 57.56% from the prior year.
- Intangibles steadied at $71.6 million in Q1 2026 per MLECW's latest filing, from $71.6 million in the prior quarter.
- Over five years, Intangibles peaked at $177.3 million in Q2 2024 and troughed at $3.8 million in Q1 2023.
- A 5-year average of $48.4 million and a median of $9.0 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2025: Intangibles jumped 3711.59% in 2023, then tumbled 57.56% in 2025.
- Over 5 years, Intangibles stood at $8.5 million in 2022, then decreased by 19.53% to $6.9 million in 2023, then soared by 32.1% to $9.1 million in 2024, then soared by 690.65% to $71.6 million in 2025, then changed by 0.0% to $71.6 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $71.6 million, $71.6 million, and $75.3 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.60 Mn |
| Dec 31, 2025 | 71.60 Mn |
| Jun 30, 2025 | 75.26 Mn |
| Dec 31, 2024 | 9.06 Mn |
| Sep 30, 2024 | 8.95 Mn |
| Jun 30, 2024 | 177.33 Mn |
| Mar 31, 2024 | 7.75 Mn |
| Dec 31, 2023 | 6.86 Mn |
| Sep 30, 2023 | 8.33 Mn |
| Jun 30, 2023 | 175.29 Mn |
| Mar 31, 2023 | 3.82 Mn |
| Dec 31, 2022 | 8.52 Mn |
| Jun 30, 2022 | 4.60 Mn |